BCG Vaccine Recruiting Phase 3 Trials for Tislelizumab (DB14922)
Also known as: Product containing antigen of live attenuated Mycobacterium bovis (medicinal product)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0155789 (BCG Vaccine) | Recruiting | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT06441110 | Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer | Treatment |